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Results of Colorectal Cancer Screening of the National
Cancer Screening Program in Korea, 2008
I n t r o d u c t i o n
Colorectal cancer screening is known to contribute to reduction of
incidence and mortality of colorectal cancer through detection of
precursor lesions of cancer or early stage cancer, and the five-year
survival rate of colorectal cancer diagnosed early was reported to
around 90% (1,2). In addition, the screening has declined mortality
of the cancer. In 12 to 18 years after beginning of cancer screening,
the mortality rate of colorectal cancer became lower by 16% (3) and
it was found to reduce mortality rate of persons aged 50 to 75 years (4).
In Korea, 2007 Annual Report of Korea Central Cancer Registry
showed that the incidence rate of colorectal cancer ranked third in
males by recording 49.7 per 100,000 population and the rate recorded
the fourth highest level or 33.9 per 100,000 population in females (5).
In particular, the incidence rate of colorectal cancer had increased
every year and its mortality rate also tended to rise (5,6). Many
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Purpose
This study aims to investigate the current situation of national colorectal cancer screening by
analyzing participation rates, positive rates of screening methods and screening rate of secon-
dary screening tests in colorectal screening of the national cancer screening program in 2008.
Materials and Methods
With database about target population and screened individuals of the national cancer
screening program, the results of target population and participants of colorectal cancer
screening in 2008 were analyzed. Among adults aged over 50 years of medical aid and bene-
ficiaries of national health insurance paying lower 50% premiums in the total subscribers,
4,640,365 were target population of colorectal cancer screening and the data of 984,915
undergoing fecal occult blood test (FOBT) as a primary screening were analyzed. 
Results
The colorectal cancer screening rate was 21.2% and the rates of national health insurance
subscribers, females and the elderly aged 60-64 years were higher than those of others. The
recipients with a positive result in FOBT recorded approximately 7.5%. Medical aid
beneficiaries (7.9%), males (8.8%) and seniors aged over 75 years (9.1%) showed higher
positive rates than the average one. Out of the FOBT positive recipients, 43.0% took a secondary
screening and the rate undergoing colonoscopy (31.4%) was higher than that of doing double-
contrast barium enema test (11.6%).
Conclusion
Colorectal cancer screening rate of medical aid beneficiaries and people paying lower 50%
premiums among national health insurance subscribers, was different according to demographic
characters (gender, age and types of health insurance). This finding meant that screening for
the vulnerable needed to be encouraged by considering socio-demographic characters. Addi-
tionally, more efforts were necessary to increase the secondary screening rate of people with a
positive result in primary one.
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researches insisted that because colorectal cancer had very long
biological natural history as an advanced cancer (7) and long symptom-
free interval but it could be treated through early detection, screening
and preventive treatment were effective (8,9). For the national
cancer screening program to detect and treat cancer early and to
decrease mortality of cancer in South Korea, stomach, breast and
cervix cancer screening have been conducted for medical aid bene-
ficiaries, whose medical accessibility is weak, since 1999. In 2002
the target population was extended to medical aid beneficiaries and
a low-income bracket paying lower 20% premiums among the national
health insurance subscribers. In 2003, liver cancer screening was
added and the target population became larger by including people
paying lower 30% premiums among the total subscribers. In 2004
by adding colorectal cancer screening, the cancer screening program
for five major cancer (stomach, liver, colorectal, breast and cervical
cancer) was established (10). Since the range of target population
was enlarged to medical aid beneficiaries and people paying lower
50% premiums among the people insured by national health in-
surance, the program has been maintained up to 2008. 
The national colorectal cancer screening began in 2004, and
males and females aged over 50 years take fecal occult blood test
(FOBT) every year and participants with a positive result undergo
an additional screening such as colonoscopy and double-contrast
barium enema test (DCBE). Although studies on tests for colorectal
cancer screening and their meaning and cost-effectiveness have been
partially reported, researches on the current situation of the national
colorectal cancer screening program are still insufficient. This study
examined results of colorectal cancer screening according to demo-
graphic characteristics in 2008. In addition, we investigated the pro-
cess of the colorectal cancer screening and characteristics of screening
tests by analyzing participation rates according to test methods.
M a t e r i a l s  a n d  M e t h o d s
1 Study population
This study utilized the database of target population and parti-
cipants of colorectal cancer screening of 2008 national cancer
screening program. The target population was adults aged over 50
years among medical aid beneficiaries and national health insurance
subscribers. For the subscribers, they or their dependants who paid
lower 50% premiums based on those of November, 2007 (monthly
67,800 or less than 67,800 won for employee insured and 56,500 or
less than 56,500 won for self-employed insured), were included in
this study. When the data about the monthly premiums did not exist,
the target population were selected by considering current premiums
compared to those on the standard month (11). According to the
inclusion criteria, totally 7,522,452 were the total target population
of colorectal national cancer screening program and out of them
4,640,365 were the target population of colorectal cancer screening
in 2008. 
Colorectal cancer is recommended to be screened every year and
FOBT was performed as a primary screening test by using fecal
immunochemical tests (reversed passive haemagglutination assay
[RPHA] or latex agglutination test) or fecal porphyrin quanti-
fication. For the participants with a positive result in FOBT, colono-
scopy or DCBE test was conducted as a additional screening test.
When DCBE result had abnormal findings (polypus, probably
cancer, colorectal cancer and other diseases than cancer), colonoscopy
was conducted additionally. When colonoscopy found abnormal
findings (polypus, suspected colorectal cancer, colorectal cancer and
others) biopsy was utilized according to decision of a physician (11).
To analyze the current situation of colorectal cancer screening, the
participants were defined as persons with at least one among a result
of FOBT, a result in colonoscopy, result in DCBE, a result of biopsy
or a result of final outcomes in screening record. Out of 985,148
with at least one of them in the record, 984,915 were recruited as
participants in 2008 by excluding 111 ones aged less than 50 years,
101 ones thought as persons not screened without personal infor-
mation and 21 already diagnosed cancer patients. In summary, the
target population and the participants of colorectal cancer screening
of the colorectal national cancer screening program in 2008 were
4,640,365 and 984,915, respectively.
2 Data analysis
Demographic characteristics examined in this study were age,
types of insurance and region. Age was divided into subgroups by
five years with the subjects aged over 50 years and the elderly aged
75 years was analyzed as a subgroup. Types of insurance were
classified into medical aid beneficiaries and national health insurance
subscribers. Region was divided into 16 cities and or provinces by
using the specific number of organizing public health centers.
The results of screening were classified based on contents of the
result sheet reported to National Health Insurance Cooperation. In
the sheet, final outcomes of colorectal cancer were ‘normal’, ‘need a
follow-up’, ‘need diagnostic work-up for cancer’, ‘need treatment
for cancer’ and ‘other diseases than cancer’. ‘Normal’ meant that a
result of biopsy, colonoscopy or double-contrast barium enema test
was normal or that FOBT showed a negative result. ‘Need a follow-
up’ was written when biopsy revealed inflammatory, hyperplastic or
pathologic findings, low/high grade adenoma or dysplasia, when
colonoscopy or double-contrast barium enema test found polypus or
when FOBT result was positive. ‘Need diagnostic work-up for cancer’
meant that colorectal cancer was suspected and inspection was
needed immediately, and ‘need treatment for cancer’ showed that
colorectal cancer was diagnosed and treatment for it was necessary
immediately. ‘Other diseases than cancer’ was written for other
diseases not related with colorectal cancer.
The results of the screening were analyzed with chi square test by
demographic variables such as gender, age, type of insurance and
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region and by screening tests like FOBT, colonoscopy, DCBE and
others. FOBT positive rate and participation rates of secondary
screening tests were calculated with 95% confidence interval (CI)
and all data analysis was conducted with SAS version 9.1 (SAS Inc.,
Cary, NC, USA). 
R e s u l t s
1 Participation rate of colorectal cancer screening in
Korea in 2008
When the current situation of colorectal cancer screening in 2008
was examined, 984,915 out of totally 4,640,365 target population
participated in the screening with the participation rate of 21.2% in
average (Table 1). The screening rate of national health insurance
subscribers was higher than that of medical aid beneficiaries by
recording 23.0% and 12.6%, respectively. The rate of females was
slightly higher than that of males by recording 21.9% and 20.5%,
respectively. For age, the screening rate recorded the highest level or
27.5% in seniors aged 60 to 64 years and the lowest level or 7.8% in
those aged over 75 years. For region, while the screening rate was
the highest in Busan and Daejeon by recording 25.0%, it was the
lowest in Jeonnam by recording 14.6%. When the results of colo-
rectal cancer screening of the participants were investigated, 93.8%
(924,080), 2.0% (19,722), 0.6% (5,867) 0.1% (509) and 3.5%
(34,737) were found to be normal, need a follow-up, need a work-
up for cancer, need treatment for cancer and be other diseases than
cancer, respectively. 
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No. of Negative result of FOBTs* Positive result of FOBTs*
participants No. % 95% CI� No. % 95% CI�
Total 984,915 911,347 92.5 (92.5-92.6) 73,568 7.5 (7.4-7.5)
Insurance
Medical aid 100,168 92,223 92.1 (91.9-92.2) 7,945 7.9 (7.8-8.1)
National health insurance 884,747 819,124 92.6 (92.5-92.6) 65,623 7.4 (7.4-7.5)
Gender
Male 446,590 407,357 91.2 (91.1-91.3) 39,233 8.8 (8.7-8.9)
Female 538,325 503,990 93.6 (93.6-93.7) 34,335 6.4 (6.3-6.4)
Age (yr)
50-54 276,603 257,283 93.0 (92.9-93.1) 19,320 7.0 (6.9-7.1)
55-59 203,084 188,830 93.0 (92.9-93.1) 14,254 7.0 (6.9-7.1)
60-64 220,798 204,613 92.7 (92.6-92.8) 16,185 7.3 (7.2-7.4)
65-69 144,673 132,945 91.9 (91.7-92.0) 11,728 8.1 (8.0-8.3)
70-74 94,864 86,860 91.6 (91.4-91.7) 8,004 8.4 (8.3-8.6)
≥75 44,893 40,816 90.9 (90.7-91.2) 4,077 9.1 (8.8-9.3)
Region 
Seoul 196,048 182,476 93.1 (93.0-93.2) 13,572 6.9 (6.8-7.0)
Busan 98,789 93,361 94.5 (94.4-94.7) 5,428 5.5 (5.3-5.6)
Daegu 53,714 50,673 94.3 (94.1-94.5) 3,041 5.7 (5.5-5.9)
Daejeon 29,054 27,069 93.2 (92.9-93.5) 1,985 6.8 (6.5-7.1)
Incheon 44,575 41,154 92.3 (92.1-92.6) 3,421 7.7 (7.4-7.9)
Gwangju 21,153 19,421 91.8 (91.4-92.2) 1,732 8.2 (7.8-8.6)
Ulsan 13,567 12,996 95.8 (95.5-96.1) 571 4.2 (3.9-4.5)
Gyeonggi 190,167 172,717 90.8 (90.7-90.9) 17,450 9.2 (9.1-9.3)
Gangwon 34,134 30,803 90.2 (89.9-90.6) 3,331 9.8 (9.4-10.1)
Chungbuk 34,552 32,588 94.3 (94.1-94.6) 1,964 5.7 (5.4-5.9)
Chungnam 48,451 44,502 91.9 (91.6-92.1) 3,949 8.2 (7.9-8.4)
Jeonbuk 39,520 37,569 95.1 (94.8-95.3) 1,951 4.9 (4.7-5.2)
Jeonnam 39,426 33,293 84.4 (84.1-84.8) 6,133 15.6 (15.2-15.9)
Gyeongbuk 69,075 64,478 93.3 (93.2-93.5) 4,597 6.7 (6.5-6.8)
Gyeongnam 61,639 57,661 93.6 (93.4-93.7) 3,978 6.5 (6.3-6.6)
Jeju 11,051 10,586 95.8 (95.4-96.2) 465 4.2 (3.8-4.6)
Table 2. Results of fecal occult blood test in National Cancer Screening Program in Korea, 2008
*fecal occult blood test, �confidence interval.
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2 Results of fecal occult blood test
Out of the 984,915 FOBT results, 73,568 (7.5%) and 911,347
(92.5%) showed positive and negative results in FOBT, respectively
(Table 2). The positive rate was relatively slightly higher in medical
aid beneficiaries than in national health insurance subscribers by
recording 7.9% (95% CI, 7.8 to 8.1) and 7.4% (95% CI, 7.4 to 7.5),
respectively. The positive rate of males was higher than that of
females by recording 8.8% (95% CI, 8.7 to 8.9) and 6.4% (95% CI,
6.3 to 6.4), respectively. The positive rate of the elderly aged over 75
years showed the highest level or 9.1% (95% CI, 8.8 to 9.3) and for
region the rate of Jeonnam was the highest by recording 15.6%
(95% CI, 15.2 to 15.9). 
When 73,568 participants with a positive result in FOBT were
analyzed according to age and region, adults aged 50 to 54 years
accounted for the largest part or 26.3% while adults aged over 75
years did for the smallest part or 5.5% (Table 3). For region, among
adults aged 50 to 54 those in Ulsan had the largest portion or 31.0%
and those in Jeju captured the smallest portion or 22.6%. On the
contrary, among adults aged over 75 years those in Jeju and Ulsan
accounted for the largest (9.9%) and the smallest portions (3.0%),
respectively. 
3 Follow-up rate for positive results of fecal occult
blood test
The national cancer screening program provided colonoscopy or
DCBE as a secondary screening test for participants with a positive
result in FOBT. Out of 73,568 showing the positive result in FOBT,
No. of positive Age
FOBT 50-54 (%) 55-59 (%) 60-64 (%) 65-69 (%) 70-74 (%) ≥75 (%)
Total 73,568 19,320 (26.3) 14,254 (19.4) 16,185 (22.0) 11,728 (15.9) 8,004 (10.9) 4,077 (5.5)
Seoul 13,572 3,455 (25.5) 2,820 (20.8) 3,287 (24.2) 2,164 (15.9) 1,241 (9.1) 605 (4.5)
Busan 5,428 1,323 (24.4) 1,047 (19.3) 1,266 (23.3) 882 (16.3) 612 (11.3) 298 (5.5)
Daegu 3,041 895 (29.4) 631 (20.8) 599 (19.7) 472 (15.5) 309 (10.2) 135 (4.4)
Daejeon 1,985 532 (26.8) 423 (21.3) 410 (20.7) 305 (15.4) 208 (10.5) 107 (5.4)
Incheon 3,421 1,069 (31.3) 719 (21.0) 742 (21.7) 448 (13.1) 299 (8.7) 144 (4.2)
Gwangju 1,732 508 (29.3) 362 (20.9) 409 (23.6) 236 (13.6) 142 (8.2) 75 (4.3)
Ulsan 571 177 (31.0) 117 (20.5) 131 (22.9) 85 (14.9) 44 (7.7) 17 (3.0)
Gyeonggi 17,450 4,824 (27.6) 3,312 (19.0) 3,831 (22.0) 2,747 (15.7) 1,845 (10.6) 891 (5.1)
Gangwon 3,331 783 (23.5) 590 (17.7) 726 (21.8) 568 (17.1) 456 (13.7) 208 (6.2)
Chungbuk 1,964 521 (26.5) 382 (19.5) 424 (21.6) 305 (15.5) 214 (10.9) 118 (6.0)
Chungnam 3,949 997 (25.3) 704 (17.8) 828 (21.0) 610 (15.5) 514 (13.0) 296 (7.5)
Jeonbuk 1,951 463 (23.7) 383 (19.6) 380 (19.5) 298 (15.3) 260 (13.3) 167 (8.6)
Jeonnam 6,133 1,413 (23.0) 1,149 (18.7) 1,347 (22.0) 1,096 (17.9) 737 (12.0) 391 (6.4)
Gyeongbuk 4,597 1,076 (23.4) 790 (17.2) 897 (19.5) 826 (18.0) 646 (14.1) 362 (7.9)
Gyeongnam 3,978 1,179 (29.6) 770 (19.4) 795 (20.0) 609 (15.3) 408 (10.3) 217 (5.5)
Jeju 465 105 (22.6) 55 (11.8) 113 (24.3) 77 (16.6) 69 (14.8) 46 (9.9)
Table 3. Proportion (%) of positive fecal occult blood test (FOBT) by age and region in National Cancer Screening Program in Korea, 2008 
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Fig. 1. Participation rate of follow-up among positive fecal occult
blood test (FOBT) persons in National Cancer Screening Program
in Korea, 2008. *double contrast barium enema.
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31,671 underwent a secondary screening test and the participation
rate was 43.0% (95% CI, 42.7 to 43.4) (Fig. 1). As 23,117 and 8,554
underwent colonoscopy and DCBE as a secondary screening test
with the participation rate of 31.4% (95% CI, 31.3 to 31.6) and
11.6% (95% CI, 11.4 to 11.9), respectively, the colonoscopy rate
was higher than that of DCBE. The national cancer screening
program recommended that persons with abnormal finding in
DCBE took colonoscopy additionally. Among 2,422 with abnormal
findings in DCBE 198 (participation rate 8.1%; 95% CI, 7.0 to 9.2)
underwent colonoscopy. In a narrowed analysis, it was 143 who had
‘probably cancer’ or ‘colorectal cancer’ among 198 DCBE abnormal
people, and 24 took colonoscopy (participation rate 16.8%; 95% CI,
10.7 to 22.9) out of 143 (data not shown). The program recom-
mended that persons with abnormal findings in colonoscopy to have
biopsy, and 9,973 out of 15,926 with abnormal findings in colono-
scopy underwent biopsy (participation rate 62.6%; 95% CI, 61.9 to
63.4). Among 558 observed to have ‘probably cancer’ or ‘colorectal
cancer’, 500 took biopsy (participation rate 89.6%; 95% CI, 87.1 to
92.1) (data not shown).
4 Results of colonoscopy and double contrast barium
enema 
Results of colonoscopy and DCBE were compared by designating
the participants showing a positive result in FOBT and undergoing
each of the two tests as 100 (Fig. 2). ‘Normal’ accounted for 31.8%
and 71.5% in the results of colonoscopy and DCBE, respectively, so
the latter fraction was two times higher than that in the former one.
The fractions of ‘Polyp’ were 41.2% and 5.3% in the results of
colonoscopy and DCBE, respectively, and those of ‘probably cancer’
were 1.2% and 1.5% in the results of colonoscopy and DCBE,
respectively. ‘Colorectal cancer’ was observed in 1.2% and 0.2% of
the participants undergoing colonoscopy and DCBE, respectively,
and the fraction of the former test was higher than that of the latter test. 
D i s c u s s i o n
The target population of colorectal cancer screening in national
cancer screening program in 2008 was totally 4,640,365 and their
participation rate was averagely 21.2%. FOBT positive rate out of
the participants was approximately 7.9% and males, the elderly aged
over 75 years and medical aid beneficiaries recorded relatively
higher positive rates compared to females, other age groups and
people insured health insurance, respectively. For secondary screening
rate of the participants with a positive result in FOBT, the rate of
colonoscopy was higher than that of DCBE.
That FOBT was conducted as a primary screening test of colorectal
cancer in the national cancer screening program in Korea, which is
similar with the national colorectal cancer screening program in
England, Japan and Finland operating (8), and persons showing a
positive result in FOBT underwent colonoscopy and DCBE (12-14).
Colorectal cancer screening program has been operated since 2004
and we have been reporting our program results in a monograph
every year. Target population of colorectal cancer screening tended
to increase from 2.26 million in 2004 to 3.27 million in 2005, 4.40
million in 2006 and 4.34 million in 2007 (15). The target population
of a current colorectal cancer screening conducted in 2008 was
about 4.60 million and out of them 0.98 million participated in the
screening by recording the rate or 21.2%. The level was slightly
lower than 25.7% or 1.73 million out of 6.73 million target population
of colorectal cancer screening shown by a report (16) of National
Health Insurance Cooperation in 2008 investigating the total benefi-
ciaries of national health insurance. In addition, even though a direct
comparison is hard to be performed, the participation rate of FOBT
or colonoscopy within 10 years was 50 to 60% in the U.S. in 2006
and the participation rate of FOBT every two years or of colonoscopy
within five years recorded 28 to 53% in Canada in 2008 (14). So
South Korea needs more efforts to encourage the colorectal cancer
screening rate in the national cancer screening program. In com-
parison of participation rates according to demographic characteristics,
the rates were even by gender and age but the rate of seniors aged
over 75 years reduced sharply. As the screening rate of national
health insurance subscribers was two times higher than that of medical
aid beneficiaries, this finding suggested that types of insurance could
mean economic differences and socio-economic differences could
lead to differences in screening rates. However, because various
factors such as comorbidity, accessibility of medical institutions for
screening, educational background and recognition on diseases were
not considered, a direct interpretation on correlation between economic
levels and screening rates had some limitations in this study. In the
meantime, the results of colorectal cancer screening showed that
medical aid beneficiaries and older recipients recorded higher rates
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Fig. 2. Proportion of results of colonoscopy and double contrast
barium enema (DCBE) in the positive group of fecal occult blood
test.
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of additional tests, so the screening of the vulnerable needed to be
encouraged.
Among the participants of a primary colorectal cancer screening,
FOBT positive rate was about 7.5%. As this study did not include
national health insurance subscribers paying higher 50% premiums
and private health examination, it could not represent the total
people in South Korea. Despite these limitations, the positive rate
was compared with the results of national cancer screening in
foreign countries to determine the level of South Korea roughly. In
the screening of Japan conducted with about 4.00 million adults
aged over 40 years in 1995, the FOBT positive rate was 7.3% (7).
The pilot study of England reported in 2004 (13) showed that the
colorectal cancer screening rate was approximately 59.2% but the
FOBT positive rate was about 1.6%. As other studies in Korea, a
randomized clinical trial in Gumi found that the FOBT positive rate
of the general public was around 1.0 to 2.4% (7), and it was said that
the positive rate of persons visiting health examination centers of
hospitals from January, 2004 to April, 2005 was around 1.8% (17).
The difference in FOBT positive rates of the national screening
program and community-based studies was thought to be caused by
considering that the national screening program was conducted by
hospitals and clinics around the nation. In this study, the regional
distribution of FOBT positive rate showed relatively higher deviation
from 4.2 to 15.6% and the rate of Jeonnam was outstandingly high.
When the rates were stratified according to region and age, the
positive rate of Jeonnam was higher than that of other regions but
there was no significant increase by age and no specific correlation
according to region and age in the distribution of positive rates.
Therefore, the deviation was considered to be caused by properties
of health examination institutions. However, it is the third year of
the quality control the National Cancer Screening Program including
FOBT tests by the Ministry of Health and Welfare, National Cancer
Center of Korea and with academic societies. We expect that the
discrepancy of quality of the FOBT tests between institutions may
diminish and the quality overall to be increased afterward. For
gender, males recorded 1.4 times higher positive rate or 8.8% than
females and for age the elderly aged over 65 years showed a high
positive rate by recording 8.1 to 9.1%. Although this study could not
determine correlation between older age and higher positive rate of
FOBT and between older age and higher incidence rate and mortality
rate of colorectal cancer, it showed at least that the tendency of
higher FOBT positive rate at older age was same with the tendency
of incidence of colorectal cancer by age in South Korea (5,6). 
The participants with a positive result in FOBT were recom-
mended to undergo colonoscopy or DCBE and the participation rate
of colonoscopy was about 2.7 times higher than that of DCBE by
recording 31.4% and 11.6%, respectively. Additional analysis on
difference in participation rates of the two secondary tests by gender,
age, region and types of insurance was performed although its
results were not presented as results. According to the analysis,
colonoscopy rate was higher in males (32.1%) and national health
insurance subscribers (32.2%) than the average rate or 31.4% but
DCBE rate was higher in females (12.0%) and medical aid benefi-
ciaries (13.1%) than the average rate or 11.6%. In addition, colono-
scopy rate was decreased at older age by recording 17.2 to 37.1%
and DCBE rate did not show a tendency according to age by recording
10.5 to 12.9%. For region, colonoscopy rate was higher in 14 regions
except two ones (Gwangju and Gangwon) and its deviation was
19.2 to 54.7%. These results suggested that gender, types of
insurance and age affected preference to or recognition on more
invasive colonoscopy needing longer examination time. The diffe-
rence in participation rates of secondary screening tests by region
was observed and it was considered to be caused by the difference
in the real condition of medical institutions and medical circum-
stances. Future studies were necessary to determine that clearly.
According to a study assuming MarKov model in terms of cost-
effectiveness of colorectal cancer screening tests (18), as a colono-
scopy screening was effective in reducing mortality rate compared
to others and showed a high cost-effectiveness. A research performed
in South Korea also insisted that colonoscopy was cost-effective (9).
As a secondary test was recommended based on these results, the
participation rate of colonoscopy was considered to be high. In addi-
tion, persons with abnormal findings in DCBE were recommended
to undergo colonoscopy in the screening process, so the participation
rate of colonoscopy was higher. Colonoscopy rate out of persons
with abnormal findings in DCBE and biopsy rate out of persons
with abnormal findings in colonoscopy recorded 8.1% and 62.6%,
respectively, and the rates of persons found to have ‘probably cancer’
or ‘colorectal cancer’ were higher than the former ones by recording
16.8% and 89.6%, respectively. Like this, as abnormal findings
included ‘polypus’, ‘probably cancer’, ‘colorectal cancer’ and ‘other
diseases than cancer’, high rates of ‘polyps’ and ‘other diseases than
cancer’ were considered to provoke reduced participation rate of
secondary tests in total participants with abnormal findings. In
particular, the rate of persons showing a positive result in FOBT but
not taking secondary test recorded a high level or 57.0%. That was
considered to be because this study analyzed only the data of the
national cancer screening program, and if cases undergoing secondary
tests through private health examination or private medical sector
were included the secondary screening rate was expected to become
higher. Moreover, even though persons were recommended to
undergo a secondary screening test, low recognition on colonoscopy
or DCBE and inconvenience of taking it were thought to increase
the rate of not attending secondary screening. This study found that
the secondary colorectal cancer screening rate was low although the
national program provided free secondary test for persons with a
positive result in FOBT and that needed to be dealt with properly.
Among persons with a positive result in FOBT, those observed to
have cancer in secondary tests such as colonoscopy and DCBE
accounted for approximately 1.2% and 0.2%, respectively, and those
done to have ‘probably cancer’ were 1.2% and 1.5%, respectively.
Considering that FOBT positive rate showed a large deviation by
region and its average was higher than those in previous studies, the
result suggested that more efforts to improve the sensitivity of FOBT
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were necessary. Foreign studies also reported that the sensitivity of
FOBT was lower by recording 30 to 50% (8). In future, it is needed
to supplement FOBT and to enhance policies to increase the effect
of the national colorectal screening based on cost-effectiveness
studies using national data on colonoscopy and DCBE as secondary
screening tests. 
C o n c l u s i o n
This study was conducted to investigate the results of the national
cancer screening program and to assess outcomes of colorectal
cancer screening by analyzing the colorectal cancer screening in the
national cancer screening program in 2008. In future, more efforts to
increase the colorectal cancer screening rate need to be continued
and specialized advertisement strategies according to age, gender
and region are also necessary. Also, a faithful participation such as
higher participation rates of secondary tests should be guided and
high-quality screening should be provided in all health examination
institutions through quality control or education.
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